|
[1]
|
Teede, H.J., Misso, M.L., Costello, M.F., Dokras, A., Laven, J., Moran, L., Piltonen, T., Norman, R.J. and International PCOS Network (2018) Recommendations from the International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Fertility and Sterility, 110, 364-379. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Sayutti, N., Abu, M.A. and Ahmad, M.F. (2022) PCOS and Role of Cu-mulus Gene Expression in Assessing Oocytes Quality. Frontiers in Endocrinology (Lausanne), 13, Article ID: 843867. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
He, F.F. and Li, Y.M. (2020) Role of Gut Microbiota in the De-velopment of Insulin Resistance and the Mechanism Underlying Polycystic Ovary Syndrome: A Review. Journal of Ovarian Research, 13, Article No. 73. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Yang, T., Yang, Y., Zhang, Q., Liu, D., et al. (2022) Homeo-static Model Assessment for Insulin Resistance Is Associated with Late Miscarriage in Non-Dyslipidemic Women Un-dergoing Fresh IVF/ICSI Embryo Transfer. Frontiers in Endocrinology (Lausanne), 13, Article ID: 880518. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Tosi, F., Villani, M., Migazzi, M., et al. (2021) Insulin-Mediated Substrate Use in Women with Different Phenotypes of PCOS: The Role of Androgens. The Journal of Clinical Endo-crinology & Metabolism, 106, e3414-e3425. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Hoeger, K.M, Dokras, A. and Piltonen, T. (2021) Update on PCOS: Consequences, Challenges, and Guiding Treatment, The Journal of Clinical Endocrinology & Metabolism, 106, e1071-e1083. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Bannigida, D.M., Nayak, B.S. and Vijayaraghavan, R. (2020) Insulin Resistance and Oxidative Marker in Women with PCOS. Archives of Physiology and Biochemistry, 126, 183-186. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Pérez-López, F.R., Ornat, L., López-Baena, M.T., et al. (2021) Circulating Kisspeptin and Anti-Müllerian Hormone Levels, and Insulin Resistance in Women with Poly-cystic Ovary Syndrome: A Systematic Review, Meta-Analysis, and Meta-Regression. The European Journal of Obstet-rics & Gynecology and Reproductive Biology, 260, 85-98. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Li, M., Chi, X., Wang, Y., Setrerrahmane, S., Xie, W. and Xu, H. (2022) Trends in Insulin Resistance: Insights into Mechanisms and Therapeutic Strategy. Signal Transduction and Tar-geted Therapy, 7, Article No. 216. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Ajmal, N., Khan, S.Z. and Shaikh, R. (2019) Polycystic Ovary Syndrome (PCOS) and Genetic Predisposition: A Review Article. European Journal of Obstetrics & Gynecology and Reproductive Biology: X, 3, Article ID: 100060. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Ding, H., Zhang, J., Zhang, F., Zhang, S., Chen, X., Liang, W. and Xie, Q. (2021) Resistance to the Insulin and Elevated Level of Androgen: A Major Cause of Polycystic Ovary Syn-drome. Frontiers in Endocrinology (Lausanne), 12, Article ID: 741764. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Qi, X.Y., Yun, C.Y., Pang, Y.L., et al. (2021) The Impact of the Gut Microbiota on the Reproductive and Metabolic Endocrine System. Gut Microbes, 13, e1894070. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Zeng, B., Lai, Z., Sun, L., et al. (2019) Structural and Func-tional Profiles of the Gut Microbial Community in Polycystic Ovary Syndrome with Insulin Resistance (IR-PCOS): A Pilot Study. Research in Microbiology, 170, 43-52. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Zhao, X., Jiang, Y., Xi, H., Chen, L. and Feng, X. (2020) Ex-ploration of the Relationship between Gut Microbiota and Polycystic Ovary Syndrome (PCOS): A Review. Geburtshilfe und Frauenheilkunde, 80, 161-171. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
莫丽敏, 刘成华, 管章春, 等. 新型胰岛素抵抗小鼠模型(eLtaStrans)肠道菌群改变及其对糖耐量的影响[J]. 中华内分泌代谢杂志, 2022, 38(5): 409-416. [Google Scholar] [CrossRef]
|
|
[16]
|
Yang, Y.L., Zhou, W.W., Wu, S., Tang, W.L., Wang, Z.W., Zhou, Z.Y., Li, Z.W., Huang, Q.F., He, Y. and Zhou, H.W. (2021) Intestinal Flora Is a Key Factor in Insu-lin Resistance and Contributes to the Development of Polycystic Ovary Syndrome. Endocrinology, 162, bqab118. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Shi, X.Y., Huang, A., Xie, D.W. and Yu, X.L. (2019) Association of Vitamin D Receptor Gene Variants with Polycystic Ovary Syndrome: A Meta-Analysis. BMC Medical Genetics, 20, Ar-ticle No. 32. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Miao, C.Y., Fang, X.J., Chen, Y. and Zhang, Q. (2020) Effect of Vitamin D Supplementation on Polycystic Ovary Syndrome: A Meta-Analysis. Experimental and Therapeutic Medicine, 19, 2641-2649. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Menichini, D. and Facchinetti, F. (2020) Effects of Vitamin D Supple-mentation in Women with Polycystic Ovary Syndrome: A Review. Gynecological Endocrinology, 36, 1-5. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Luo, Y.L., Wang, Q., Cui, C.C., et al. (2020) Research Pro-gress on the Effect of Vitamin D Deficiency on Polycystic Ovary Syndrome Patients with Insulin Resistance. Chinese Journal of Reproduction and Contraception, 40, 506-510.
|
|
[21]
|
Rudnicka, E., Kunicki, M., Suchta, K., Machura, P., Grymowicz, M. and Smolarczyk, R. (2020) Inflammatory Markers in Women with Polycystic Ovary Syndrome. BioMed Research International, 2020, Article ID: 4092470. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Rudnicka, E., Suchta, K., Grymowicz, M., Calik-Ksepka, A., Smolar-czyk, K., Duszewska, A.M., Smolarczyk, R. and Meczekalski, B. (2021) Chronic Low Grade Inflammation in Patho-genesis of PCOS. International Journal of Molecular Sciences, 22, Article No. 3789. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Zhu, Q., Yao, Y., Xu, L., Wu, H., Wang, W., He, Y., et al. (2022) Ele-vated SAA1 Promotes the Development of Insulin Resistance in Ovarian Granulosa Cells in Polycystic Ovary Syndrome. Reproductive Biology and Endocrinology, 20, Article No. 4. [Google Scholar] [CrossRef] [PubMed]
|